Lifecore Biomedical (LFCR) News Today $6.92 +0.05 (+0.73%) As of 11:51 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFCR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Deutsche Bank AG Reduces Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR)Deutsche Bank AG lessened its stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 91.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 25,433 shares of the company's stock after selling 290,286 shares during thJune 3 at 3:28 AM | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by BNP Paribas Financial MarketsBNP Paribas Financial Markets lessened its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 72.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,966 shares of the company's stock aftJune 1 at 3:20 AM | marketbeat.comInsider Selling: Lifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells 96,137 Shares of StockLifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 96,137 shares of the company's stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $6.75, for a total value of $648,924.75. Following the completion of the sale, the insider now owns 1,554,103 shares in the company, valued at $10,490,195.25. This represents a 5.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.May 30, 2025 | marketbeat.comAron R. English Sells 150,419 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) StockLifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 150,419 shares of the company's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $7.12, for a total transaction of $1,070,983.28. Following the completion of the transaction, the insider now owns 264,180 shares in the company, valued at approximately $1,880,961.60. This trade represents a 36.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.May 30, 2025 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Aron R. English Sells 1,139,504 SharesLifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 1,139,504 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $6.50, for a total value of $7,406,776.00. Following the completion of the sale, the insider now directly owns 414,599 shares in the company, valued at $2,694,893.50. This trade represents a 73.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.May 30, 2025 | marketbeat.comLifecore Biomedical (NASDAQ:LFCR) shareholders have endured a 37% loss from investing in the stock five years agoMay 29, 2025 | finance.yahoo.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Aron R. English Sells 96,137 SharesMay 29, 2025 | insidertrades.comLifecore Biomedical Names Mark DaFonseca Chief Commercial OfficerMay 27, 2025 | globenewswire.comQ4 Earnings Estimate for LFCR Issued By William BlairLifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Equities researchers at William Blair issued their Q4 2025 earnings estimates for Lifecore Biomedical in a research note issued to investors on Wednesday, May 21st. William Blair analyst M. Smock anticipates that the company will earn $0.04May 25, 2025 | marketbeat.comWilliam Blair Initiates Coverage on Lifecore Biomedical (NASDAQ:LFCR)William Blair initiated coverage on Lifecore Biomedical in a report on Wednesday. They set an "outperform" rating on the stock.May 23, 2025 | marketbeat.comLifecore stock gains on Outperform rating by William BlairMay 22, 2025 | investing.comWhat Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?May 22, 2025 | msn.comWilliam Blair Initiates Coverage of Lifecore Biomedical (LFCR) with Outperform RecommendationMay 22, 2025 | msn.comGreenhaven Road Capital Main Fund Q1 2025 Investor LetterMay 19, 2025 | seekingalpha.comInsider Selling: Lifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells 12,334 Shares of StockMay 17, 2025 | insidertrades.comInsider Selling: Lifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells 45,698 Shares of StockLifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 45,698 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $7.03, for a total transaction of $321,256.94. Following the sale, the insider now directly owns 1,662,574 shares of the company's stock, valued at $11,687,895.22. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Major shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.May 14, 2025 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Stock Position Lifted by Legion Partners Asset Management LLCLegion Partners Asset Management LLC raised its stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 49.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,431,823 shares of the comMay 14, 2025 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells $321,256.94 in StockMay 13, 2025 | insidertrades.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells $111,087.47 in StockMay 8, 2025 | insidertrades.com325 Capital LLC Grows Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR)325 Capital LLC boosted its position in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 57.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,162,466 shares of the company's stock after acquiringMay 4, 2025 | marketbeat.comBoothbay Fund Management LLC Has $647,000 Holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR)Boothbay Fund Management LLC trimmed its position in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 53.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 87,142 shares of the company's stock after sMay 3, 2025 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by Marshall Wace LLPMarshall Wace LLP decreased its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 33.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 133,191 shares of the company's stock after selling 67,509 shares during tMay 3, 2025 | marketbeat.comLifecore Biomedical, Inc.'s (NASDAQ:LFCR) hedge funds shareholders had a great week as one-year returns increased after a 11% gain last weekMay 2, 2025 | finance.yahoo.comInvesco Ltd. Purchases Shares of 555,607 Lifecore Biomedical, Inc. (NASDAQ:LFCR)Invesco Ltd. acquired a new position in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 555,607 shares of the company's stock, valued at approximately $4,128,000. InvesApril 28, 2025 | marketbeat.comGeode Capital Management LLC Raises Stock Holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR)Geode Capital Management LLC grew its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 14.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 685,746 shares of the company's stockApril 28, 2025 | marketbeat.comLifecore Biomedical to Participate at Upcoming CDMO Live 2025 ConferenceApril 22, 2025 | globenewswire.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Acquired by Greenhaven Road Investment Management L.P.Greenhaven Road Investment Management L.P. boosted its stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 62.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,616,146 shApril 20, 2025 | marketbeat.com116,538 Shares in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Acquired by Alpha Wave Global LPAlpha Wave Global LP bought a new stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 116,538 shares of the company's stock, valued at approximately $866,00April 20, 2025 | marketbeat.comLifecore Biomedical, Inc.: Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 17, 2025 | finanznachrichten.deLifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 16, 2025 | globenewswire.comLifecore appoints Salus as chief legal, administration officerApril 14, 2025 | markets.businessinsider.comLifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration OfficerApril 14, 2025 | globenewswire.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Stock Position Decreased by Wittenberg Investment Management Inc.Wittenberg Investment Management Inc. lowered its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 80.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,223 shares of the company's stock aftApril 6, 2025 | marketbeat.comLifecore Biomedical (NASDAQ:LFCR) Announces Earnings Results, Misses Estimates By $0.05 EPSLifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.05). Lifecore Biomedical had a negative net margin of 12.52% and a negative return on equity of 315.23%.April 5, 2025 | marketbeat.comLifecore Biomedical (LFCR) Gets a Hold from BarringtonApril 5, 2025 | markets.businessinsider.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call TranscriptApril 5, 2025 | insidermonkey.com43,700 Shares in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Purchased by Rangeley Capital LLCRangeley Capital LLC acquired a new stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 43,700 shares of the company's stock,April 5, 2025 | marketbeat.comLifecore Biomedical Reports Q3 Fiscal 2025 ResultsApril 4, 2025 | tipranks.comLifecore Biomedical targets 12% revenue CAGR and expanded CDMO pipeline by 2027April 3, 2025 | msn.comLifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call TranscriptApril 3, 2025 | seekingalpha.comLifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateApril 3, 2025 | globenewswire.comCraig-Hallum Keeps Their Buy Rating on Lifecore Biomedical (LFCR)April 1, 2025 | markets.businessinsider.comLifecore Biomedical (LFCR) to Release Earnings on ThursdayLifecore Biomedical (NASDAQ:LFCR) will be releasing earnings on Thursday, April 3, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633032)March 29, 2025 | marketbeat.comLifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025March 27, 2025 | globenewswire.comDCF Advisers LLC Acquires 251,511 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR)DCF Advisers LLC lifted its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 87.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 539,989 shares of the company's stock after purchasing an additional 251,5March 22, 2025 | marketbeat.comHumanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation SyndromeMarch 17, 2025 | finance.yahoo.comHumanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation SyndromeMarch 17, 2025 | globenewswire.comLifecore Biomedical (NASDAQ:LFCR) Trading 0.5% Higher - Should You Buy?Lifecore Biomedical (NASDAQ:LFCR) Trading Up 0.5% - Here's WhyMarch 9, 2025 | marketbeat.comIs Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now?March 7, 2025 | insidermonkey.comGreenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)March 7, 2025 | msn.com Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address LFCR Media Mentions By Week LFCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFCR News Sentiment▼0.380.86▲Average Medical News Sentiment LFCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFCR Articles This Week▼105▲LFCR Articles Average Week Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arcus Biosciences News Today Ardelyx News Today Intellia Therapeutics News Today Phibro Animal Health News Today Collegium Pharmaceutical News Today CureVac News Today Wave Life Sciences News Today Spyre Therapeutics News Today Avadel Pharmaceuticals News Today Syndax Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFCR) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFCR with Qtrade Free LFCR Stock Alerts